Suppliers / Compounds & building blocks
Oregon Therapeutics
Paris, France · oregon-therapeutics.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the supplier and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Oregon Therapeutics is developing XCE853, a cancer therapy based on inhibition of protein disulfide isomerase. The company focuses on oncology, with priority indications in ovarian cancer and advanced pancreatic cancer, and is based in Paris, France, with a contact location in Boonton, New Jersey, USA.
Their website has a general contact form; we send your quote request through it.
What they offer
XCE853 development
Develops XCE853 as a targeted oncology drug candidate for clinical development.
- Sites
- Paris, France · Boonton, USA
- Address
- 301 Rockaway Valley Rd, Boonton, NJ 07005, USA
Similar suppliers. 2bind Pharma Services, 3C Therapeutics, AAPharmaSyn, Abeomics
Found in a contract services directory. Listing built from oregon-therapeutics.com. Work here? Claim this listing.